The earliest symptoms of bladder cancer may go unnoticed by patients with colorblindness or similar color vision deficiencies ...

The study highlights how color vision deficiency can delay bladder cancer diagnosis, increasing mortality risk and ...

A new Stanford Medicine study suggests that colorblindness may obscure one of the earliest warning signs of bladder cancer ...

Colorblind people might have a unique disadvantage in noticing an early warning sign of certain cancers, a new study suggests.

Out of sight, out of mind. A new study suggests a common eye condition could be quietly masking one of the only early warning ...

A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.

Recognizing the sight of blood in urine, the most common first sign of bladder cancer, is often the impetus that leads people ...

What Is Transurethral Resection of Bladder Tumor (TURBT)? If you have bladder cancer or suspected bladder cancer, your doctor has probably told you that you need a transurethral resection of the ...

D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory ...

Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...

Chugai files regulatory application with MHLF for additional indication of Tecentriq to treat adjuvant therapy for MRD-positive bladder cancer: Tokyo Thursday, January 29, 2026, 0 ...